LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma

Changsheng Shi(Wenzhou Medical University), Mingxu Yu(Wenzhou Medical University), Gending Xu(Wenzhou Medical University), Xingcheng Lin(Ningxia University), Ya Luo(Wenzhou Medical University), Xiangpang Xie(Wenzhou Medical University), Bingru Zheng(Wenzhou Medical University), Songsong Pan(Wenzhou Medical University), Qing Yang(Guangzhou University of Chinese Medicine)
Cancer Biology & Therapy
April 24, 2020
10.1080/15384047.2020.1738908
Cited by 42

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
|British Journal of Cancer|2018|156
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
|Science Translational Medicine|2019|138